The clinical manifestations and management of COVID-19-related liver injury.
作者信息
Su Tung-Hung, Kao Jia-Horng
机构信息
Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
出版信息
J Formos Med Assoc. 2020 Jun;119(6):1016-1018. doi: 10.1016/j.jfma.2020.04.020. Epub 2020 Apr 24.
Abstract
摘要
相似文献
1
The clinical manifestations and management of COVID-19-related liver injury.新型冠状病毒肺炎相关肝损伤的临床表现与处理
J Formos Med Assoc. 2020 Jun;119(6):1016-1018. doi: 10.1016/j.jfma.2020.04.020. Epub 2020 Apr 24.
2
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?我们用瑞德西韦（一种老药新包装）找到了治疗新冠病毒肺炎的万灵药了吗？
J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217.
3
COVID-19 and liver disease: An update.新型冠状病毒肺炎与肝脏疾病：最新进展
Gastroenterol Hepatol. 2020 Oct;43(8):472-480. doi: 10.1016/j.gastrohep.2020.06.006. Epub 2020 Jul 3.
4
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.冠状病毒病（COVID-19）大流行：与时间赛跑
Curr Top Med Chem. 2020;20(16):1434-1437. doi: 10.2174/1568026620999200413145654.
5
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
6
Race to find COVID-19 treatments accelerates.寻找新冠病毒治疗方法的竞赛加速。
Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.
7
Audio Interview: Covid-19 and the President.音频访谈：新冠疫情与总统
N Engl J Med. 2020 Oct 8;383(15):e104. doi: 10.1056/NEJMe2031183.
8
Communicating Science in the Time of a Pandemic.疫情时期的科学传播
JAMA. 2020 Aug 4;324(5):443-444. doi: 10.1001/jama.2020.12535.
9
[COVID-19: a cardiological point-of-view].[新型冠状病毒肺炎：心脏病学视角]
Dtsch Med Wochenschr. 2020 Jul;145(15):1063-1067. doi: 10.1055/a-1164-4161. Epub 2020 Jul 30.
10
Treatments for COVID-19: where are we now?2019冠状病毒病的治疗方法：我们目前处于什么阶段？
Br J Community Nurs. 2020 Aug 2;25(8):412-413. doi: 10.12968/bjcn.2020.25.8.412.
引用本文的文献
1
Successful liver transplant in a patient with acute cholestatic liver failure due to COVID-19 infection: A case report.1例因新型冠状病毒肺炎感染导致急性胆汁淤积性肝衰竭患者的肝移植成功：病例报告
J Liver Transpl. 2021 Apr-Jun;2:100007. doi: 10.1016/j.liver.2021.100007. Epub 2021 Apr 22.
2
Potential Complementary Effect of Zinc and on Gut Health and Immunity: A Narrative Review.锌与益生菌对肠道健康和免疫的潜在互补作用：综述。
Nutrients. 2024 Mar 19;16(6):887. doi: 10.3390/nu16060887.
3
Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis.生物信息学和系统生物学方法揭示新型冠状病毒肺炎与非酒精性肝炎之间的共享基因和分子机制。
Front Mol Biosci. 2023 Jun 19;10:1164220. doi: 10.3389/fmolb.2023.1164220. eCollection 2023.
4
Liver Damage and COVID-19: At Least a "Two-Hit" Story in Systematic Review.肝损伤与新冠病毒病：系统评价中至少是一个“双重打击”的故事
Curr Issues Mol Biol. 2023 Apr 4;45(4):3035-3047. doi: 10.3390/cimb45040199.
5
Hepatic Disorders and COVID-19: From Pathophysiology to Treatment Strategy.肝脏疾病与 COVID-19：从病理生理学到治疗策略。
Can J Gastroenterol Hepatol. 2022 Dec 8;2022:4291758. doi: 10.1155/2022/4291758. eCollection 2022.
6
COVID-19-associated liver injury, role of drug therapy and management: a review.新型冠状病毒肺炎相关肝损伤、药物治疗作用及管理：综述
Egypt Liver J. 2022;12(1):66. doi: 10.1186/s43066-022-00230-y. Epub 2022 Nov 23.
7
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis.SARS-CoV-2 进入因子在慢性肝炎患者中的表达。
Viruses. 2022 Oct 29;14(11):2397. doi: 10.3390/v14112397.
8
Successful Treatment of Subacute Thyroiditis After Recombinant COVID-19 Vaccination Using Traditional Chinese Medicine: A Case Report.中医药成功治疗重组新型冠状病毒疫苗接种后亚急性甲状腺炎：一例报告
Cureus. 2022 Oct 26;14(10):e30716. doi: 10.7759/cureus.30716. eCollection 2022 Oct.
9
The Effect of COVID 19 on Liver Parenchyma Detected and measured by CT scan Hounsfield Units.新冠病毒对肝脏实质的影响：通过CT扫描亨氏单位进行检测和测量
J Res Med Sci. 2022 Mar 17;27:26. doi: 10.4103/jrms.JRMS_1228_20. eCollection 2022.
10
Dynamic Changes of Liver Function Indexes in Patients with Different Clinical Types of COVID-19.新型冠状病毒肺炎不同临床类型患者肝功能指标的动态变化
Int J Gen Med. 2022 Jan 26;15:877-884. doi: 10.2147/IJGM.S347291. eCollection 2022.
本文引用的文献
1
Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection.新型冠状病毒肺炎合并乙型肝炎病毒感染住院患者的临床特征
Virol Sin. 2020 Dec;35(6):842-845. doi: 10.1007/s12250-020-00276-5. Epub 2020 Aug 24.
2
Clinical Features of COVID-19-Related Liver Functional Abnormality.新型冠状病毒病相关肝功能异常的临床特征。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1561-1566. doi: 10.1016/j.cgh.2020.04.002. Epub 2020 Apr 10.
3
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.新型冠状病毒肺炎患者的非酒精性脂肪性肝病：一项回顾性研究。
J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8.
4
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
5
Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.失代偿期肝硬化患者中新型冠状病毒2型感染的预防
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):528-529. doi: 10.1016/S2468-1253(20)30080-7. Epub 2020 Mar 17.
6
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.冠状病毒与免疫抑制患者：第三次疫情期间的实际情况
Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24.
7
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.
8
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
9
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤：管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
10
First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan.台湾首例 2019 年冠状病毒病（COVID-19）肺炎病例。
J Formos Med Assoc. 2020 Mar;119(3):747-751. doi: 10.1016/j.jfma.2020.02.007. Epub 2020 Feb 26.
Zotero 插件